1
Participants
Start Date
July 12, 2019
Primary Completion Date
September 20, 2019
Study Completion Date
September 20, 2019
HLT® Transcatheter System
Transcatheter aortic valve replacement using The HLT® Transcatheter System (HLT System) in patients with symptomatic heart disease due to severe aortic stenosis who are judged by the Heart Team to be at Intermediate or High Risk for aortic valve replacement surgery (Heart Team agrees that the risk of 30-day mortality is ≥ 3%).
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec
Lead Sponsor
HLT Inc.
INDUSTRY